Leap Therapeutics Inc (LPTX)
3.13
-0.14
(-4.28%)
USD |
NASDAQ |
May 02, 16:00
3.18
+0.05
(+1.60%)
After-Hours: 20:00
Leap Therapeutics Price to Book Value: 1.332 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.332 |
| May 01, 2024 | 1.392 |
| April 30, 2024 | 1.320 |
| April 29, 2024 | 1.307 |
| April 26, 2024 | 1.383 |
| April 25, 2024 | 1.349 |
| April 24, 2024 | 1.400 |
| April 23, 2024 | 1.362 |
| April 22, 2024 | 1.366 |
| April 19, 2024 | 1.192 |
| April 18, 2024 | 1.26 |
| April 17, 2024 | 1.277 |
| April 16, 2024 | 1.268 |
| April 15, 2024 | 1.277 |
| April 12, 2024 | 1.379 |
| April 11, 2024 | 1.326 |
| April 10, 2024 | 1.294 |
| April 09, 2024 | 1.452 |
| April 08, 2024 | 1.098 |
| April 05, 2024 | 1.081 |
| April 04, 2024 | 1.068 |
| April 03, 2024 | 1.077 |
| April 02, 2024 | 1.120 |
| April 01, 2024 | 1.171 |
| March 28, 2024 | 1.132 |
| Date | Value |
|---|---|
| March 27, 2024 | 1.183 |
| March 26, 2024 | 1.056 |
| March 25, 2024 | 1.022 |
| March 22, 2024 | 1.073 |
| March 21, 2024 | 1.086 |
| March 20, 2024 | 1.086 |
| March 19, 2024 | 0.9365 |
| March 18, 2024 | 0.9109 |
| March 15, 2024 | 0.9407 |
| March 14, 2024 | 0.9365 |
| March 13, 2024 | 0.9748 |
| March 12, 2024 | 1.064 |
| March 11, 2024 | 1.056 |
| March 08, 2024 | 1.063 |
| March 07, 2024 | 1.012 |
| March 06, 2024 | 1.003 |
| March 05, 2024 | 1.105 |
| March 04, 2024 | 1.144 |
| March 01, 2024 | 1.203 |
| February 29, 2024 | 1.186 |
| February 28, 2024 | 1.212 |
| February 27, 2024 | 1.233 |
| February 26, 2024 | 1.275 |
| February 23, 2024 | 1.262 |
| February 22, 2024 | 1.271 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3984
Minimum
Sep 25 2023
10.43
Maximum
Sep 24 2021
2.180
Average
1.878
Median
Aug 07 2020
Price to Book Value Benchmarks
| Cutera Inc | -- |
| OrthoPediatrics Corp | 2.014 |
| AIM ImmunoTech Inc | 2.113 |
| Protalix BioTherapeutics Inc | 2.524 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 42.62 |
| Price | 3.13 |
| Earnings Yield | -154.0% |
| Market Cap | 80.13M |